Clostridium butyricum and Its Derived Extracellular Vesicles Modulate Gut Homeostasis and Ameliorate Acute Experimental Colitis.
Clostridium butyricum and Its Derived Extracellular Vesicles Modulate Gut Homeostasis and Ameliorate Acute Experimental Colitis.
复制标题
DOI:
10.1128/spectrum.01368-22
复制
发表时间:
2022-08-31
影响因子:
3.7
通讯作者:
Xiao, Yingping
中科院分区:
文献类型:
--
作者:
Ma, Lingyan;Shen, Qicheng;Lyu, Wentao;Lv, Lu;Wang, Wen;Yu, Minjie;Yang, Hua;Tao, Shiyu;Xiao, Yingping
Microbiological treatments are expected to have a role in the future management of inflammatory bowel disease (IBD). Clostridium butyricum (C. butyricum) is a probiotic microorganism that exhibits beneficial effects on various disease conditions. Although many studies have revealed that C. butyricum provides protective effects in mice with colitis, the way C. butyricum establishes beneficial results in the host remains unclear. In this study, we investigated the mechanisms by which C. butyricum modifies the gut microbiota, produces bacterial metabolites that may be involved, and, specifically, how microbial extracellular vesicles (EVs) positively influence IBD, using a dextran sulfate sodium (DSS)-induced colitis murine model in mice. First, we showed that C. butyricum provides a protective effect against colitis, as evidenced by the prevention of body weight loss, a reduction in the disease activity index (DAI) score, a shortened colon length, decreased histology score, and an improved gut barrier function, accompanied by reduced levels of pathogenic bacteria, including Escherichia/Shigella, and an increased relative abundance of butyrate-producing Clostridium sensu stricto-1 and Butyricicoccus. Second, we also confirmed that the gut microbiota and metabolites produced by C. butyricum played key roles in the attenuation of DSS-induced experimental colitis, as supported by the profound alleviation of colitis effects following fecal transplantation or fecal filtrate insertion supplied from C. butyricum-treated mice. Finally, C. butyricum-derived EVs protected the gut barrier function, improved gut microbiota homeostasis in ulcerative colitis, and contributed to overall colitis alleviation. IMPORTANCE This study indicated that C. butyricum provided a prevention effect against colitis mice, which involved protection of the intestinal barrier and positively regulating gut microbiota. Furthermore, we confirmed that the gut microbiota and metabolites that were induced by C. butyricum also contributed to the attenuation of DSS-induced colitis. Importantly, C. butyricum-derived EVs showed an effective impact in alleviating colitis.
登录
查看更多内容
影响因子:
6.4
作者:
Codemo M;Muschiol S;Iovino F;Nannapaneni P;Plant L;Wai SN;Henriques-Normark B
通讯作者:
Henriques-Normark B
影响因子:
7.3
作者:
Grondin JA;Kwon YH;Far PM;Haq S;Khan WI
通讯作者:
Khan WI
影响因子:
29.4
作者:
Ott, Stephan J.;Waetzig, Georg H.;Schreiber, Stefan
通讯作者:
Schreiber, Stefan
影响因子:
12.2
作者:
Ma L;Ni Y;Wang Z;Tu W;Ni L;Zhuge F;Zheng A;Hu L;Zhao Y;Zheng L;Fu Z
通讯作者:
Fu Z
DOI:
10.1038/nrgastro.2017.88
发表时间:
2017-10
期刊:
Nature reviews. Gastroenterology & hepatology
影响因子:
--
作者:
Ni J;Wu GD;Albenberg L;Tomov VT
通讯作者:
Tomov VT